SCHEMBL23903122

SCHEMBL23903122

O=c1c2cc3c(cc2sc2nc4ccccc4n12)c1ccccc1n3-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.58
RAB9A P51151 6/20 0.58
SMN1; SMN2 Q16637 6/20 0.58
TP53 P04637 3/20 0.58
KDM4E B2RXH2 3/20 0.58
HPGD P15428 3/20 0.58
HSD17B10 Q99714 3/20 0.58
LMNA P02545 2/20 0.58
KMT2A Q03164 6/20 0.45
MEN1 O00255 4/20 0.45
HIF1A Q16665 1/20 0.45
PDE1B Q01064 1/20 0.44
PDE3A Q14432 1/20 0.44
PDE11A Q9HCR9 1/20 0.44
MAPT P10636 6/20 0.43
ALDH1A1 P00352 4/20 0.43
NOD2 Q9HC29 1/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 2/20 0.43
HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26227240 0.92 NPC1 (0.55) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL23902868 0.90 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL23902874 0.89 NPC1 (0.49) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL26227168 0.87 NPC1 (0.54) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL23903032 0.86 RAB9A (0.58) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL26227223 0.85 NPC1 (0.52) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL23256990 0.85 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL25500526 0.84 KDM4E (0.51) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL26227237 0.83 NPC1 (0.54) NPC1RAB9ASMN1; SMN2TP53KDM4E
SCHEMBL24513494 0.82 NPC1 (0.62) NPC1RAB9ASMN1; SMN2TP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION MERCK PATENT GMBH (DE) 2023-05-18 US disclosed
WO-2021198213-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151026-A1 MULTI-LAYER BODY FOR DIFFUSE TRANSILLUMINATION DDT, EPCAM, SLC18A3 NPC1 1782/4885RAB9A 1937/4885SMN1; SMN2 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.